ASCRS 2026: Gonioscopy Still Matters - Scorecard - MDSpire

ASCRS 2026: Gonioscopy Still Matters

  • April 14, 2026

  • 3 min

Share

Clinical Scorecard: ASCRS 2026: Gonioscopy Still Matters

At a Glance

CategoryDetail
ConditionGlaucoma
Key MechanismsDirect visualization of the iridocorneal angle.
Target PopulationPatients with glaucoma, particularly those undergoing surgery.
Care SettingGlaucoma clinics.

Key Highlights

  • Gonioscopy is essential for direct assessment of angle structures.
  • Only 49% of Medicare patients had documented gonioscopy prior to surgery.
  • Over 70% of patients lack documented gonioscopy within the first 6 months of evaluation.
  • Imaging modalities like OCT and UBM are complementary but not substitutes for gonioscopy.
  • Handheld imaging devices can enhance gonioscopy but have limitations.

Guideline-Based Recommendations

Diagnosis

  • Perform gonioscopy to assess the iridocorneal angle.

Management

  • Use gonioscopy for procedural planning and identification of secondary pathology.

Monitoring & Follow-up

  • Document gonioscopy findings consistently in patient records.

Risks

  • Inconsistent performance and documentation of gonioscopy may lead to inadequate patient assessment.

Patient & Prescribing Data

Patients with glaucoma requiring angle assessment.

Gonioscopy remains critical despite advancements in imaging technology.

Clinical Best Practices

  • Ensure gonioscopy is performed and documented in all glaucoma evaluations.
  • Utilize adjunctive imaging technologies to supplement gonioscopy findings.
  • Train staff to improve proficiency in performing gonioscopy.

References

Original Source(s)

Related Content